OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Social Drivers of Cancer Risk and Outcomes Among African American Men	108
Oncology Physician Workforce Diversity	47
PET Imaging of Metabolism, Perfusion, and Hypoxia	24
Toxicities From Antibody-Drug Conjugates	23
Health Care Policy and Disparities in Health	22
Building a Bridge to Equity in Health and Health Care in Cancer Care	22
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	22
Clinical Evidence Generation During a Pandemic	19
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	17
Stereotactic Body Radiation Therapy	17
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	17
Melanoma—Modern Treatment for Metastatic Melanoma	17
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	16
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	15
Nonoperative Management for Rectal Cancer	14
Antibody Drug Conjugates in Multiple Myeloma	13
Prostate Cancer, Race, and Health Disparity	13
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	12
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	12
Metastatic Melanoma Treatment in Special Populations	12
Germline Predisposition to Myelodysplastic Syndromes	12
Primary Prevention of Cancer	11
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	11
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	11
Diversity in Cancer Care	11

Rectal Cancer—The Only Constant Is Change	11
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	10
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	10
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	10
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	10
Updates in the Management of Uveal Melanoma	9
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	9
New Metabolomic Insights Into Cancer	9
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	9
Introduction	8
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	8
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	8
Supportive Care for Patients With Myelodysplastic Syndromes	8
Discovery of Natural Products for Cancer Prevention	8
Menopausal Hormone Therapy and Breast Cancer	8
Impact of Precision Medicine in Oncology	8
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	7
Telehealth and Technology	7
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	7
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	7
How Far We’ve Come	7
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	7